Timothy Alexander

SEED Therapeutics Secures $30M Funding, Gains FDA Clearance for Lead Drug KING OF PRUSSIA, PA — SEED Therapeutics, Inc. announced it has closed a $30 million Series A-3 financing and received U.S. Food and Drug A […]

ArriVent BioPharma Taps Brent S. Rice as Chief Commercial Officer NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has appointed Brent S. Rice as Chief Commercial Officer, bringing more than 25 years of c […]

Nationwide Voting Opens for ImageFIRST’s 5th Annual HeroesFIRST Contest KING OF PRUSSIA, PA — ImageFIRST has launched nationwide voting for its 5th Annual HeroesFIRST Contest, honoring 20 healthcare professionals r […]

pharosIQ Expands atlasIQ to Give Marketers Deeper Insight Into Global Buyers PHILADELPHIA, PA — pharosIQ announced an expansion of its atlasIQ platform, adding advanced capabilities that give B2B marketers sharper visibility i […]

STRATA Skin Sciences Study Shows Breakthrough in Vitiligo Combination Therapy HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced results from a large randomized controlled trial showing that its 308nm Excimer l […]

Coventry Marks Life Insurance Awareness Month With $6B Value Milestone FORT WASHINGTON, PA — Coventry, a leading force in the life settlement market, is marking Life Insurance Awareness Month by reaffirming its mission t […]

Helius Medical Places Bold Bet on Solana With $175M Token Acquisition NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced its first acquisition of Solana (SOL) tokens, marking the company’s ent […]

GLPI Backs $1.19B Bally’s Casino Resort to Redefine Chicago Riverfront WYOMISSING, PA — Gaming and Leisure Properties, Inc. (GLPI) and Bally’s Corporation are moving forward with a $1.19 billion project that will bring a l […]

Proscia Deepens AWS Ties to Power AI-Driven Pathology at Cloud Scale PHILADELPHIA, PA — Proscia® announced an expanded collaboration with Amazon Web Services (AWS) to tackle two of digital pathology’s biggest hurd […]

Annovis Bio Publishes Data on New Crystal Form of Lead Alzheimer’s Drug MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced the publication of a peer-reviewed article in Biomolecules detailing the pharmacokinetic p […]

FullThrottle Launches AI-Powered AdTech Platform for SMBs PHILADELPHIA, PA — FullThrottle Technologies, LLC has unveiled a newly enhanced version of its fullthrottle.ai® platform, designed to give small and mi […]

Onfolio Declares Quarterly Dividend on Series A Preferred Stock WILMINGTON, DE — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW; OTC: ONFOP) announced its Board of Directors has declared a regular quarterly dividend o […]

Oaktree’s Howard Marks Joins Alliance for Decision Education Board PHILADELPHIA, PA — The Alliance for Decision Education has appointed Howard Marks, co-chairman and co-founder of Oaktree Capital Management, to its B […]

Palvella Completes Phase 2 Trial of QTORIN Rapamycin for Cutaneous Venous Malformations WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced it has completed TOIVA, a Phase 2 proof-of-concept trial of QTORIN™ 3.9% rapamycin anh […]

Ocugen Strikes $7.5 Million Licensing Deal With Kwangdong for Gene Therapy in Korea MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has signed an exclusive licensing agreement with South Korea’s Kwangdong Pharmaceutical Co., Ltd. for the rig […]

FDA Expands Approval of Incyte’s Opzelura to Treat Pediatric Atopic Dermatitis WILMINGTON, DE — Incyte (Nasdaq: INCY) announced that the U.S. Food and Drug Administration has approved Opzelura (ruxolitinib) cream 1.5% for c […]

AKUVO Secures Vista Equity Investment to Accelerate AI-Powered Collections MALVERN, PA — AKUVO, a provider of collections and risk management software for financial institutions, announced a strategic investment from Vista E […]

Gopuff Unveils New Web Shopping Experience With Real-Time Order Tracking PHILADELPHIA, PA — Gopuff has launched a redesigned commerce experience for desktop and mobile web, introducing a suite of features aimed at p […]

AIRSUPRA Label Expanded With Evidence of Risk Reduction in Mild Asthma WILMINGTON, DE — The U.S. prescribing information for AIRSUPRA now includes results from the Phase IIIb BATURA trial, which demonstrated that the m […]

EnterpriseDB Report Warns 87% of Enterprises Risk Falling Behind in AI Race WILMINGTON, DE — EnterpriseDB (EDB) released new global research showing that most enterprises are struggling to scale agentic and generative AI, w […]